• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • Our Team
  • What We Offer
    • Primary Care
    • Commercial
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • Medicine Management
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • Specialties
        • EMIS: Cancer
        • EMIS Cardiovascular Overview
          • EMIS: Cardiovascular Disease (AF, CHD, Hypertension)
          • EMIS: Cardiovascular Disease (CVD) Prevention
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • EMIS: Peripheral Arterial Disease Guide
        • EMIS Diabetes Overview
          • EMIS Diabetes
          • EMIS: Diabetes Technology
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS: NHS Health Checks
        • EMIS: Paediatric Assessment
        • EMIS Renal Overview
          • Chronic Kidney Disease (CKD) – EMIS
        • Respiratory Overview
          • EMIS Respiratory Resources
          • BeatAsthma+ Guide for EMIS
        • EMIS: Rheumatology
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • SystmOne: NHS Health Checks
        • SystmOne: WorkWell Local Enhanced Service
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • SystmOne: Antibiotics Prescribing & Optimisation
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes
          • SystmOne: Diabetes Technology
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Respiratory Resources
          • Respiratory Infections
        • Rheumatology Overview
          • SystmOne: Osteoporosis and Fragility Fractures
          • Bone Health
      • SystmOne: Weight Management
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination SystmOne
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / SystmOne Resource Centre / Long Term Condition Management / Call/ Recall System

Call/ Recall System

CDRC can be configured to deliver Long Term Condition (LTC) Call and Recall. 

Each unit defines the LTCs that they wish to include in their call/recall system. Any condition that can be systematically recorded can be included. Most practices will include the QoF LTCs. Common additional conditions include: 

  • Patients at high risk of diabetes – NDH/IGR/history of gestational diabetes/PCOS 
  • Non-QoF respiratory diseases – E.g. pulmonary fibrosis, bronchiectasis 
  • Non-alcoholic fatty liver disease 
  • Coeliac disease 
  • Familial hypercholesterolaemia 
  • Gout 
  • Frailty 

Additionally, customised lists of patients with specific needs can also be created, e.g. patients on watchful waiting prostate cancer management. 

LTC Recall

Each patient with a relevant LTC is given a single ‘LTC Recall’ recall date. This replaces all previous condition specific recalls e.g. asthma recall, diabetes recall. The default is to set the recall in the month of birth but it can be set to any time of the year. 

Quality Control

Automatic Quality Control searches are set to monitor the system to identify patients who need a LTC recall who do not have a pending recall e.g. new patients, patients with a new diagnosis, patients where the LTC recall date has been accidentally set too far in the future or in the past. A task is sent to the administration team at regular intervals, defined by the practice, to identify these patients. 

Running The Searches

The LTC admin team defines the week they want to run the recall system. Lists of relevant patients are then created. 

* Current Week 
Recall 6M 
Recall Current Week 
Recall 
DNA x3 
Recall Housebound 6m 
Recall Housebound for Breakdown 
Recall Palliative Care 
64 
2g Jun 2017 14:55 
2g Jun 2017 14:57 
2g Jun 2017 14:57 
2g Jun 2017 14:57 
2g Jun 2017 14:57

The above screenshot shows a typical set of reports but this can be customised for each unit. 

Recall Current Week – will display all those patients who are due a LTC recall this week, or 4 weeks ago or 8 weeks ago. This allows the patients to be invited at monthly intervals as required by QoF. Patients who are housebound or on the palliative care list are excluded. 

Recall 6M – identifies patients who need a 6 month review. The default setting is that 6m recalls will be generated for: 

  • Patients with Diabetes (unless they are in remission) 
  • Patients with CKD severe enough to warrant 6 month assessment (as defined by NICE) 

Recall Housebound and Housebound 6M – similar to the above reports but for housebound patients who are likely to need a different management pathway. 

Recall DNAx3 – patients who have not attended LTC review after three invitations. The unit can then decide how to manage these patients e.g. exception report, further attempts to contact. 

Recall Palliative Care – a list of patients with LTCs but also on the palliative care list. The recommended approach is to arrange clinician review of the patient’s record and make an individual decision about whether a ‘standard’ LTC review is needed (e.g. stable palliative patients) or whether alternative provision is needed. 

Invitation

The unit can use the lists created above to arrange invitations.  Invitations can be sent by post, SMS text message or email. The unit can choose to send appointments or invitations to make an appointment.  

Conducting a Review

When the patient is seen for review the clinician uses the LTC Master template. This displays the conditions the patient has, previous reviews and the most recent LTC recall information. The tests the patient needs are displayed along with other ‘tasks’ such as need for immunisation, screening (NHS Health Checks, diabetes screening etc.) and drug monitoring tests. 

Homel LettersjAppts HO 
Contact details not verified for Online Services 
This patient is registered for Online Services but does not have a verified method of 
communication such as mobile phone number or email address 
OCS CHO without MI 
Patient has coronary heart disease and has never had an Ml 
O OCS CKD 3-5 
Patient has CKD stages 3-5 
OCS Diabetes- type 2 with proteinuria 
Type 2 diabetes with microalbuminuria or proteinuria 
OCS Gout (not on treatment) 
Patient has gout and not on repeat medication 
Bp OCS Hypertension 
Patient has hypertension 
TestF8C 
Patient due FBC 
Test HbA1c 
Patient due HbA1c 
TestLFTs 
Patient due LFTs 
Asthma 
46 copo 
CHO 
Stroke Dcs 
PAD Dcs 
O CKD 
Diabetes (retired 
High Risk of 
NAFLD 
BP Hypertension DCS 
Hypothyroidism 
Diabetes LIK Score 
AF Atrial 
Hean Failure 
Epilepsy 
Mental Heath 
Dementia Archived 
Learning Disabiltie• 
27 Jul 2016 
27 Jul 2016 
27 Jul 2016 
27 Jul 2016 
- 04 Aug 2015 
- 04 dui 2016 
- 04 Jul 2017 
Diabetic annual review (66AS ) 
Hypertension annual review [XalyE) 
Chronic kidney disease annual review CXaMGE) 
Coronary heart disease annual review CXalgh) 
LTC Recall 
LTC Recall 
LTC Recall 
Core Data Entry 
Create new Long Term Condtion Review done task 
Superseded 
Superseded

The clinician then completes the basic information needed for almost all reviews e.g. weight, smoking, lifestyle via the Core Data Entry button, then works their way through the conditions that the patient has completing the information/interventions specific to that condition. For some combination of conditions and depending on the skill mix  at the unit, this might be done over more than one appointment. Once all the conditions have been reviewed, the LTC Recall date is reset by right clicking on the most recent LTC recall. The user will be prompted to entering a new LTC recall date in 1 year. The user does not need to set any routine 6 month reviews – these are automatically created based on the annual LTC review. 

Seen 
Cancel 
Awating Resuts 
Follow-on Supersede 
- Generate 
Generate Letter Using Integrated Word

If an interim review is deemed necessary that wouldn’t be part of routine care (e.g. a patient with diabetes needs a review at 3 months) the scheduled task function is used to generate this follow up. 

Advanced Options

If needed a unit can set up a more advanced recall system based on the skill mix in their unit. This aims to maximise the efficient use of staff whilst minimising inconvenience for patients. 

The unit defines the pathways that patients will follow depending on staff competencies. 

A simple example: 

HCA15 
HCA5 
co 15 
GP call 
Any LTC exceptT4, asthma, epilepsy alone SeesHCAand shedeterminesfollow up 
T4 and notin HCA15 
Asthma and notin HCA15 or HCA5 
Epilepsy and not in HCA15, 5 no asthma 
Sees HCA and she determines follow up

A complex example:

HCAIO Tri20 CS20 GPIO 
HCAIO Tri20 GPIO 
HCAIO LN20 CS20 GPIO 
HCAIO LN20 GPIO 
HCAIO CS20 GPIO 
HCAIO Tri20 CS20 
HCAIO LN20 CS20 
HCAIO Tri20 
HCAIO LN20 
HCAIO CS20 
HCAIO GPIO 
HCAIO 
DM AND psych/spfl 
DM AND psych&pU no 
CVD/HF/CKD3BAND psych/gpll (No 0M) 
CVD/HF/CKD3BAND psych/gp!! (no No 0M) 
B*pand psych/gpll (no DM/CVD/HF/CKD38) 
Ngspand DM (no psych/gpLl) 
B*pand CVD/HF/CKD3B (no psych/epi!, No DM 
DM and no rgp, no 
CVD/HF/CKD3Band no C*p, no psych/gpll no DM 
Ngspand at least 1 HCA condition (no DM, CVD, HF, CKD3B, no psych/epilepsy 
39>2 (no HCA condition, no DM, CVD, HF, CKD3B, no psych/epilepsy) 
psych/epilepsy Or RA and none of the above (no c_gsp, DM, CVD/HF/CKD3B 
HCA condition (except thyroid) and none of the above 
Thyroid alone

Patients are sent an invitation asking them to contact the surgery to arrange their appointment. When the patient rings, admin/reception staff can easily see what pathway the patient requires. In the example below, the patient needs a 10 minute appointment with the HCA for blood tests and then an appointment with one of the practice nurses (different times due to different levels of experience). It also prompts the admin staff to remind the patient to bring a urine sample if needed. 

Annual Review *CAI O THEN CS20 or 8830 
Annual/6M Review urine sample 
Please ask the patient to bring a morning urine sample 
Contact details not verified for Online Services 
This patient is registered for Online Services but does not have a verified method of 
communication such as mobile phone number or email address 
OCS CHO without MI 
Patient has coronary heart disease and has never had an Ml 
O OCS CKD 3-5 
Patient has CKD stages 3-5 
OCS Diabetes - type 2 with proteinuria 
Type 2 diabetes with microalbuminuria or proteinuria 
OCS Gout (not on treatment)

Advantages of the System

  • Extremely simple for the user. 
  • Can be very complex  
  • Allows any number of LTC conditions to be managed in one system 
  • Integrated care 
  • Quality control built in to ensure no patients are missed 
  • Significantly reduces to possibility of problems due to user error e.g. forgetting to add recall dates or setting the wrong recall 
  • Evidence based 
  • Can maximise use of staff 
  • Minimises inconvenience and duplication for patients 

Appendices

Appendix 1 – Disease Specific Recalls

Disease specific recalls that are counted in the recall recovery system: 

  • Asthma 
  • Asthma annual review 
  • Atrial fibrillation 
  • Atrial Fibrillation Annual Review 
  • CHD
  • CHD Annual Review 
  • CHD Monitoring 
  • CHRONIC DISEASE MANAGEMENT 
  • Chronic Disease Monitoring 
  • Chronic Disease Review 
  • Chronic Disease Review 12m 
  • Chronic Disease Review 3m 
  • Chronic Disease Review 6m 
  • CKD 
  • COPD 
  • COPD ANNUAL REVIEW 
  • Coronary Heart Disease annual review 
  • DEMENTIA 
  • Dementia Annual Review 
  • Dementia Review 
  • Diabetes 
  • Diabetes 3month Review 
  • Diabetes 6 month check 
  • Diabetes 6 month review 
  • Diabetes 6month review 
  • Diabetes Annual Review 
  • DIABETES MELLITUS 
  • Diabetic 6 month review 
  • Diabetic Annual Review 
  • Epilepsy 
  • Heart Failure 
  • Heart Failure Annual Review 
  • Hypertension 
  • HYPERTENSION ANNUAL REVIEW 
  • Hypertension Monitoring 
  • Hypothyroidism 
  • hypothyroidism annual review 
  • Learning Disabilities 
  • PVD Monitoring 
  • Rheumatoid Annual Review 
  • Rheumatoid Arthritis 
  • Rheumatoid Arthritis Annual Review 
  • Rheumatoid Arthritis Monitoring 
  • Stroke 

Appendix 2 – Higher Risk Patients
 Higher Risk 
Any LTC >=4 DNAs in the past 2 years Significantly overdue drug monitoring 
Asthma >6 SABA in last 12 months  Last ACT score >20 LABA on repeat and no ICS High dose ICS LAMA Aminophylline Biologics Likely moderately severe asthma Exacerbations (>2 in 12, severe/admission last 12m, life threatening) Exacerbation in last 2y but no ICS Concordance issue – LABA, LAMA Exceeding usual quantities of long acting inhalers 
AF Anticoagulation should be considered 
CHD BP > 150/90 Poor concordance (anticoagulants, antiplatelets, betablocker, ccb, diuretics, RAS drugs, statin) 
CKD CKD G3aA3, G3bA2,3, G4/5 
COPD Severe COPD MRC 4+5 >=3 exacerbations in the last year >=3 course of prednisolone in the last year CAT score >20 Concordance issues with long term inhalers 
Diabetes Scoring system (1 point for each of) Hba1c>100 Hba1c >75  Hba1c >58 BP >=150/90 High risk feet Mod risk feet ACR >3  ACR>30 Lipid Total Cholesterol>5 Poor concordance hypoglycaemics Poor concordance lipid lowering Poor concordance RAS drugs Poor concordance diuretics Poor concordance CCBs  Score >=3 
Heart failure NYHA 3 and 4 Sicubatril Eplerenone, spironolactone 
Hypertension BP>=150/90 Poor concordance beta blockers Poor concordance alpha blockers Poor concordance lipid lowering Poor concordance RAS drugs Poor concordance diuretics Poor concordance CCBs 
Learning disability BMI <19 or >40 On antidepressants, antipsychotics, anxiolytics, hypnotics, opioids, gabapentinoids, lithium Two or more (non LD) LTCs No health check for 2 years History of aspiration pneumonia or PEG Any drug monitoring is significantly overdue 
PAD BP > 150/90 Poor concordance (anticoagulants, antiplatelets, betablocker, ccb, diuretics, RAS drugs, statin) 
Stroke BP > 150/90 Poor concordance (anticoagulants, antiplatelets, betablocker, ccb, diuretics, RAS drugs, statin) 

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
contact-cdrc@healthinnovationnenc.org.uk
This website is operated by Health Innovation North East and North Cumbria. Suite A, 2nd Floor, 1 Citygate, Gallowgate, Newcastle upon Tyne NE1 4WH. Registered in England and Wales, Company Registration Number: 08727658
  • Terms of Reference
  • Privacy policy
  • Terms of use
  • Cookie Policy (UK)
  • Accessibility Statement

Copyright © 2025 Clinical Digital Resource Collaborative

Manage Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}